April 10, 2021
Business News

ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board


LOS ANGELES–()–ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM – CEO of Diet ID, Inc, founder and former director of Yale University’s Yale-Griffin Prevention Research Center and past president of the American College of Lifestyle Medicine, to its Scientific Advisory Board (SAB). Dr. Katz is a leading expert in nutrition, health promotion and the prevention of chronic disease through his work as a researcher, author and clinician.

As CEO of Diet ID, Dr. Katz oversees a team working to make diet a vital sign, leveraging an advance in dietary assessment. He also serves as president for True Health Initiative, a non-profit organization that he…



Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Why Amazon workers in Alabama voted against union – Fox Business
Article feature image
Brooklyn woman gets COVID 3 weeks after Johnson & Johnson vaccine – New York Post
EIG ondertekent infrastructuurovereenkomst van $ 12,4 miljard met Aramco